Real-time enrollment status for this colorectal neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:37 AM UTC
| NCT Number | NCT06131840 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 914 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT06131840 is currently recruiting participants. This clinical trial study for colorectal neoplasms is actively seeking new participants at 19 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06131840 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06131840 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.